1. Home
  2. GL vs PODD Comparison

GL vs PODD Comparison

Compare GL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$170.92

Market Cap

11.9B

Sector

Finance

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$143.08

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
PODD
Founded
1900
2000
Country
United States
United States
Employees
3695
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
10.3B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
GL
PODD
Price
$170.92
$143.08
Analyst Decision
Buy
Buy
Analyst Count
11
21
Target Price
$167.27
$341.48
AVG Volume (30 Days)
473.6K
1.3M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
0.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.30
Revenue
N/A
$2,708,100,000.00
Revenue This Year
$9.64
$24.55
Revenue Next Year
$5.61
$19.18
P/E Ratio
$10.21
$113.61
Revenue Growth
N/A
30.73
52 Week Low
$116.73
$140.63
52 Week High
$170.11
$354.88

Technical Indicators

Market Signals
Indicator
GL
PODD
Relative Strength Index (RSI) 75.09 38.64
Support Level $147.40 $143.11
Resistance Level N/A $161.35
Average True Range (ATR) 3.20 6.00
MACD 1.44 1.15
Stochastic Oscillator 95.88 12.79

Price Performance

Historical Comparison
GL
PODD

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: